• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8,396
4,567
4,456
3,816
3,742

COUNTRY

3,276
1,103
308
291
270

CATEGORIES

  • 1,036
  • 184
    • 41
    • 307
    • 43
  • 202
  • 807
    • 52
  • 511
  • 662
  • 228
  • 61
  • 71
  • 889
  • 1,552
  • 80
  • 20
  • 517
  • 1,470
  • 2,468
    • 83
    • 122
    • 65
    • 63
    • 37
    • 33
    • 12
    • 16
  • 23
  • 275
  • 33
  • 2,754
  • 840
  • 233
SHOW ALL…

PRICE

4,857
9,691
21,490
31,344

PUBLISHED

4,663
6,416
12,618
31,344

PRODUCT TYPE

28,544
1,212
1,178
171
73
58
42
22
21
16
6
1

Pharmaceuticals

(31,344 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

Diabetic Neuropathy - Pipeline Review, H1 2015

Diabetic Neuropathy - Pipeline Review, H1 2015 Summary This, ‘Diabetic Neuropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathy’s therapeutic pipeline. This report...

June 2015
FROM

Ewing Sarcoma - Pipeline Review, H1 2015

Ewing Sarcoma - Pipeline Review, H1 2015 Summary This, ‘Ewing Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report provides comprehensive...

June 2015
FROM

Belarus Pharmaceuticals and Healthcare Report Q3 2015

Collapsing external trade will have a highly damaging impact on living standards in Belarus, impacting incomes, employment and consumer sentiment, and we expect the pharmaceutical sector to be hurt...

June 2015

Russia Pharmaceuticals and Healthcare Report Q3 2015

Multinational pharmaceutical companies will experience greater challenges over the coming year as Russia's grim economic outlook will have a significant impact on consumer demand for pharmaceuticals....

June 2015

Kazakhstan Pharmaceuticals and Healthcare Report Q3 2015

Declining real incomes will moderate the demand for pharmaceuticals in Kazakhstan in the short-term. However, continued expansion in government procurement will offset this and contribute to top line...

June 2015

India Pharmaceuticals and Healthcare Report Q3 2015

The implementation of universal healthcare in India will remain challenging and we maintain our view that a full nationwide rollout by 2019 is unlikely. This outlook is driven by the low levels of healthcare...

June 2015

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015

Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015 Summary This, ‘Bipolar Disorder (Manic Depression) - Pipeline Review, H1 2015’, provides an overview of the Bipolar Disorder (Manic Depression)’s...

June 2015
FROM

Acute Coronary Syndrome - Pipeline Review, H1 2015

Acute Coronary Syndrome - Pipeline Review, H1 2015 Summary This, ‘Acute Coronary Syndrome - Pipeline Review, H1 2015’, provides an overview of the Acute Coronary Syndrome’s therapeutic pipeline. This...

June 2015
FROM

Aspergillosis - Pipeline Review, H1 2015

Aspergillosis - Pipeline Review, H1 2015 Summary This, ‘Aspergillosis - Pipeline Review, H1 2015’, provides an overview of the Aspergillosis’s therapeutic pipeline. This report provides comprehensive...

June 2015
FROM

Advances in Cancer Research, Vol 127

Advances in Cancer Research provides invaluable information on the exciting and fast-moving field of cancer research. Here, once again, outstanding and original reviews are presented on a variety of...

June 2015

Analgesics in the United Arab Emirates

Analgesics saw 7% current value growth in 2014, which was similar to the current value CAGR of 6% recorded over the review period. Analgesics is an OTC consumer health category which is entering maturity,...

June 2015
FROM

Vitamins and Dietary Supplements in the United Arab Emirates

It is common for residents in the United Arab Emirates to maintain a diet which is low in nutrients and high in starch and fat; a situation which has led to the emergence of numerous health problems....

June 2015
FROM

Cough, Cold and Allergy (Hay Fever) Remedies in the United Arab Emirates

The residents of the United Arab Emirates suffered high rates of allergies in 2014, due on the one hand to increased urbanisation, which boosted pollution, whilst on the other hand the high number of...

June 2015
FROM

NRT Smoking Cessation Aids in the United Arab Emirates

Anti-smoking initiatives from the United Arab Emirates government in terms of awareness campaigns, stricter laws and better healthcare facilities had a positive influence on NRT smoking cessation aids...

June 2015
FROM

Calming and Sleeping in the United Arab Emirates

Health experts have claimed that Dubai’s citizens suffer from high levels of stress, with symptoms of this including musculoskeletal disorders, insomnia, ulcers, and in some cases, panic attacks. In...

June 2015
FROM

Digestive Remedies in the United Arab Emirates

In 2014 digestive remedies remained far from maturity in the United Arab Emirates. This can be attributed to low familiarity of the risks and treatment methods for digestive conditions amongst consumers....

June 2015
FROM

Nucleic Acid Therapies in Oncology Drug Pipeline Update 2015

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 281...

June 2015
FROM

Epigenetic Therapy in Oncology Drug Pipeline Update 2015

Epigenetic abnormalities are frequent events implicated in the development of many different types of tumors. The first epigenetic modification that was linked to cancer was methylation and to date...

June 2015
FROM

Cancer Stem Cells Drug Pipeline Update 2015

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs...

June 2015
FROM

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan) Summary The report is an essential source of information and analysis on the healthcare, regulatory and...

June 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S